These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9708883)

  • 1. The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis.
    Elcock FJ; Chipman JK; Roberts RA
    Arch Toxicol; 1998 Jun; 72(7):439-44. PubMed ID: 9708883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
    Hasmall SC; James NH; Soames AR; Roberts RA
    Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
    James NH; Roberts RA
    Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
    Strange J; Roberts RA
    Mutat Res; 1996 Nov; 372(1):107-13. PubMed ID: 9003537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nafenopin causes protein kinase C-mediated serine phosphorylation and loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization.
    Elcock FJ; Deag E; Roberts RA; Chipman JK
    Toxicol Sci; 2000 Jul; 56(1):86-94. PubMed ID: 10869456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor.
    Gill JH; Brickell P; Dive C; Roberts RA
    Carcinogenesis; 1998 Oct; 19(10):1743-7. PubMed ID: 9806153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of intercellular communication of rat hepatocytes by nafenopin: involvement of protein kinase C.
    Leibold E; Greim H; Schwarz LR
    Carcinogenesis; 1994 Jun; 15(6):1265-9. PubMed ID: 8020165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
    Macdonald N; Holden PR; Roberts RA
    Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
    West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA
    Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas.
    Gill JH; James NH; Roberts RA; Dive C
    Carcinogenesis; 1998 Feb; 19(2):299-304. PubMed ID: 9498280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gap-junctional-intercellular communication in intact rat liver by nongenotoxic hepatocarcinogens.
    Kolaja KL; Engelken DT; Klaassen CD
    Toxicology; 2000 Apr; 146(1):15-22. PubMed ID: 10773359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
    James NH; Roberts RA
    Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
    Hasmall S; James N; Hedley K; Olsen K; Roberts R
    Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.
    Bayly AC; Roberts RA; Dive C
    J Cell Biol; 1994 Apr; 125(1):197-203. PubMed ID: 8138571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro model of rodent nongenotoxic hepatocarcinogenesis.
    James NH; Molloy CA; Soames AR; French NJ; Roberts RA
    Exp Cell Res; 1992 Dec; 203(2):407-19. PubMed ID: 1281111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in the clonal expansion of hepatocytes in response to the coaction of epidermal growth factor and nafenopin, a rodent hepatocarcinogenic peroxisome proliferator.
    James NH; Roberts RA
    Fundam Appl Toxicol; 1995 Jun; 26(1):143-9. PubMed ID: 7657058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
    Hasmall SC; West DA; Olsen K; Roberts RA
    Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
    Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA
    Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB).
    James NH; Soames AR; Roberts RA
    Arch Toxicol; 1998 Dec; 72(12):784-90. PubMed ID: 9950075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin.
    Chevalier S; Macdonald N; Tonge R; Rayner S; Rowlinson R; Shaw J; Young J; Davison M; Roberts RA
    Eur J Biochem; 2000 Aug; 267(15):4624-34. PubMed ID: 10903494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.